Halper Sadeh LLC is investigating the merger between NextCure, Inc. and Avere Therapeutics, Inc. to determine if NextCure's shareholders are receiving a fair price. The firm questions whether NextCure's board fulfilled their duties by securing the best price, conducting a fair sales process, and providing all necessary information. NextCure shareholders will own about 1.21% of the combined company after the merger. Halper Sadeh LLC may seek additional compensation or disclosures on behalf of shareholders.
At Bitcoin Asia 2026 in Hong Kong, former Binance CEO Changpeng Zhao predicted Bitcoin will overtake gold's significance during the next bull market cycle. While gold's market cap is about $32.4 trillion, Bitcoin currently holds $1.6 trillion, with Z...
In 2026, the United States saw its share of Bitcoin's total mining hashrate decline by about 0.823%, losing roughly 55 exahash per second (EH/s), though it remains the largest miner globally. Meanwhile, China and Russia increased their share of the g...
Meta has agreed to an $18 billion legal settlement, which translates to about $1 billion per year—an amount negligible compared to its substantial revenue and earnings. The settlement resolves regulatory uncertainties, allowing Meta to focus on its c...
Genius Group, after selling its entire Bitcoin reserve to repay $8.5 million in debt, plans to rebuild its Bitcoin and AI treasuries to a combined $1.6 billion by fiscal year 2031. The company aims to grow total assets to $2 billion and will fund tre...
Veteran trader Peter Brandt revealed he remains long on Bitcoin even as the cryptocurrency struggles to break above the key resistance zone around $82,000. Bitcoin recently climbed above $80,000 but faced strong selling pressure, causing a pullback. ...
